Ultima FTTP 2mg Ultima Pharmaceuticals

£72.00

Ultima FTTP 2mg is a high-potency trenbolone acetate solution manufactured by Ultima Pharmaceuticals for detailed laboratory investigations into anabolic steroid receptor binding mechanisms and tissue-selective androgenic activity in controlled research environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima FTTP 2mg Ultima Pharmaceuticals
Ultima FTTP 2mg Ultima Pharmaceuticals
£72.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research-Grade Trenbolone Acetate Overview

Ultima FTTP 2mg is a pharmaceutical-grade trenbolone acetate injectable solution manufactured by Ultima Pharmaceuticals for in-vitro laboratory research applications. Trenbolone acetate is a potent synthetic anabolic androgenic steroid belonging to the 19-nortestosterone class, extensively studied for its high binding affinity to androgen receptors and pronounced tissue selectivity in preclinical models. Researchers at Stroid UK Shop utilise this compound to examine androgenic pathway modulation and anabolic signalling cascades in controlled laboratory settings.

Laboratory Research Applications

This trenbolone acetate formulation enables comprehensive investigations into steroid hormone receptor interactions and downstream cellular signalling pathways. Research teams study its mechanism of action through selective androgen receptor binding, examining how modifications to the 19-nortestosterone backbone affect receptor affinity and transcriptional activity. The compound’s unique structural features, including the 17β-acetate ester and double bonds at positions 9-10 and 11-12, make it valuable for comparative studies with other anabolic steroids available through our trenbolone research collection. Scientists investigate its effects on protein synthesis pathways, nitrogen retention mechanisms, and glucocorticoid receptor antagonism in cell culture models. Additional research focuses on metabolic pathway interactions and comparison studies alongside compounds from our SARM research category and peptide investigations.

Technical Specifications

Ultima FTTP 2mg Research Specifications
Parameter Value
Active Compound Trenbolone Acetate
Concentration 2mg (verify with supplier documentation)
Manufacturer Ultima Pharmaceuticals
Form Injectable Solution
CAS Number 10161-34-9
Molecular Formula C₂₀H₂₄O₃
Molecular Weight 312.4 g/mol
Storage Conditions Room temperature, protect from light

Research Compliance Statement

Ultima FTTP 2mg is manufactured exclusively for in-vitro laboratory research purposes and is not approved for human consumption, therapeutic use, or any clinical applications. This product is intended solely for qualified researchers conducting studies on anabolic steroid mechanisms, receptor binding kinetics, and cellular pathway analysis in controlled laboratory environments. Researchers must maintain appropriate safety protocols, documentation standards, and regulatory compliance when handling this research compound. All investigations should follow established scientific methodologies and institutional review guidelines for androgenic steroid research.

Related